arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

Summit Therapeutics Inc.

SMMT

$16.44 ▼ -0.67 (-3.92%) at close

31 Visible periods

24 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Summit Therapeutics Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $12.8B

Dividend Yield —

Revenue Growth None

Op. Margin —

ROIC None

FCF / Share $-0.18 ↘

Trailing P/E —

Price / Book 20.7x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Sep 23, 2026.

31-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

— —

Net Income Profit after all expenses

$-189.42M

↓ -201.1% —

FCF / Share Free cash flow per share

$-0.18

↓ -15.5% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q4 FY2018 Jan 31, 2019 10-K ↗	Q4 FY2017 Jan 31, 2018 10-K ↗
Revenue Growth YoY (%)	—	—	—	—	—	—	—	—	—	—	—	N/M	N/M	N/M	N/M	-83.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1140%)	312.3% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+3804%)	30.2% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+278%)	35.7% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+346%)	623.2% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+7690%)	-66.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-931%)	-40.7% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-609%)	N/M	22.3% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+179%)	—	—	—	—	—	—	—
EPS Growth YoY (%)	63.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-166.7% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-211.1% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-287.5% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-744.4% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-50.0% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	—	-166.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-350.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	95.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	—	78.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	88.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-550.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	—	30.0% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	37.0% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	-4.8% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	100.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	23.1% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	-17.4% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-133.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	30.8% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-30.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-201.1% Weak ↓ Weak Declining Year-over-year change in net income	-201.1% Weak ↓ Weak Declining Year-over-year change in net income	-258.1% Weak ↓ Weak Declining Year-over-year change in net income	-11.8% Weak ↑ Weak Improving Year-over-year change in net income	-4.2% Weak ↑ Weak Improving Year-over-year change in net income	-44.7% Weak ↑ Weak Improving Year-over-year change in net income	—	-164.5% Weak ↓ Weak Declining Year-over-year change in net income	-310.3% Weak ↓ Weak Declining Year-over-year change in net income	92.0% Excellent ↑ Excellent Improving Year-over-year change in net income	—	0.5% Caution ↑ Caution Improving Year-over-year change in net income	12.2% Fair ↑ Fair Improving Year-over-year change in net income	-2434.8% Weak ↓ Weak Declining Year-over-year change in net income	29.0% Excellent ↑ Excellent Improving Year-over-year change in net income	-9.1% Weak ↑ Weak Improving Year-over-year change in net income	31.3% Excellent ↑ Excellent Improving Year-over-year change in net income	-22.4% Weak ↑ Weak Improving Year-over-year change in net income	-100.1% Weak ↓ Weak Declining Year-over-year change in net income	-10.7% Weak ↑ Weak Improving Year-over-year change in net income	-59.8% Weak ↑ Weak Improving Year-over-year change in net income	-185.1% Weak ↓ Weak Declining Year-over-year change in net income	-49.1% Weak Weak Year-over-year change in net income	-177.6% Weak Weak Year-over-year change in net income	—	—	—	—	—	—	—
FCF Growth YoY (%)	—	-89.4% Weak Weak Year-over-year change in free cash flow	—	—	—	-94.3% Weak Weak Year-over-year change in free cash flow	—	—	—	-23.2% Weak Weak Year-over-year change in free cash flow	—	—	—	82.3% Excellent Excellent Year-over-year change in free cash flow	—	—	—	21.0% Good Good Year-over-year change in free cash flow	—	—	—	-236.9% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	14.1% Good Good Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q4 FY2018 Jan 31, 2019 10-K ↗	Q4 FY2017 Jan 31, 2018 10-K ↗
Effective Tax Rate (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.6% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	1.2% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.9% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.5% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.8% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—
FCF / Net Income (x)	0.75x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.65x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.47x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.48x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	—	0.98x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.69x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	0.02x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	-0.27x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.90x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.34x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	1.18x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.59x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	—	1.22x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.76x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q4 FY2018 Jan 31, 2019 10-K ↗	Q4 FY2017 Jan 31, 2018 10-K ↗
Return on Invested Capital (%)	—	—	—	—	—	—	—	-10.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-24.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-75.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-36.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-16.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-10.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-317.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-12.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-10.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-19.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-27.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-24.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-19.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-19.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-26.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-14.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-49.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-28.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.8% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-9.7% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-17.4% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—
Return on Capital (%) (%)	—	—	—	—	—	—	—	-11.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-17.4% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-24.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-17.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-9.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-6.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-210.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-10.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-13.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-19.0% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-23.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-15.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-16.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-12.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-11.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	-32.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-7.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	-30.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-300%)	-34.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-331%)	-33.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-322%)	-32.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-318%)	-24.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-262%)	-18.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-222%)	-15.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-205%)	-12.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-186%)	-31.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-306%)	-98.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-756%)	—	-21.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-243%)	-12.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-182%)	—	-15.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-201%)	-16.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-207%)	-32.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-318%)	-33.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-321%)	-32.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-317%)	-19.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-228%)	-20.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-236%)	-27.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-281%)	-17.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-214%)	-48.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-420%)	-28.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-290%)	-9.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-160%)	-11.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-177%)	-17.6% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-217%)	—	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q4 FY2018 Jan 31, 2019 10-K ↗	Q4 FY2017 Jan 31, 2018 10-K ↗
Interest Coverage (x)	—	—	—	—	—	—	—	-23.78x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-19.22x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-13.58x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	—	-7.53x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-6.28x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-64.51x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	—	-24.48x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-19.44x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	-13023.50x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—	—	—	—	—
Net Debt (USD)	$-419.37M	$-106.52M	$-225.27M	$-238.55M	$-297.87M	$-211.53M	$-104.86M	$-93.78M	$-28.43M	$-61.29M	$-71.42M	$-23.79M	$-42.12M	$-70.97M	$-348.61M	$-121.97M	—	—	$-71.79M	—	$-103.39M	$-102.19M	—	$-21.27M	—	—	$-63.84M	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q4 FY2018 Jan 31, 2019 10-K ↗	Q4 FY2017 Jan 31, 2018 10-K ↗
Revenue per Share (USD)	—	—	—	—	—	—	—	$0.00	—	—	—	$0.00	$0.00	$0.00	—	$0.00	$0.00	$0.00	—	$0.01	$0.00	$0.00	—	$0.00	$0.00	$0.00	—	$0.00	—	—	—
Basic EPS, GAAP (USD)	$-0.28	$-0.24	$-0.28	$-0.31	$-0.76	$-0.09	$-0.09	$-0.08	$-0.09	$-0.06	—	$-0.03	$-0.02	$-1.43	$-0.04	$-0.14	$-0.17	$-0.22	$0.00	$-0.20	$-0.27	$-0.21	$-0.18	$-0.26	$-0.23	$-0.09	$-0.26	$-0.20	—	—	—
Free Cash Flow per Share (USD)	$-0.18	$-0.16	—	$-0.13	—	$-0.08	—	—	—	$-0.04	—	—	—	$-0.03	—	—	—	$-0.20	—	—	—	$-0.25	—	—	$-0.28	$-0.07	—	—	—	—	—
Book Value per Share (USD)	$0.79	$0.70	$0.85	$0.26	$0.35	$0.46	$0.53	$0.59	$0.27	$0.06	$0.11	$0.14	$0.17	$0.19	—	$0.66	$0.52	$0.66	$0.85	$1.05	$1.23	$0.78	$0.24	$0.55	$0.80	$1.02	$1.17	$1.13	—	—	—
Tangible Book Value per Share (USD)	$0.79	$0.70	$0.85	$0.26	$0.35	$0.46	$0.52	$0.59	$0.27	$0.06	$0.11	$0.14	$0.17	$0.19	—	$0.65	$0.50	$0.64	$0.83	$1.03	$1.21	$0.75	$0.23	$0.51	$0.80	$1.02	$1.14	$1.13	—	—	—
Basic Weighted Avg Shares (shares)	778.18M	775.46M	—	743.42M	742.62M	738.08M	—	726.66M	707.90M	701.79M	—	697.74M	697.69M	378.16M	—	148.58M	99.65M	98.07M	—	97.45M	90.65M	82.82M	—	67.23M	67.23M	67.22M	—	32.10M	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q4 FY2018 Jan 31, 2019 10-K ↗	Q4 FY2017 Jan 31, 2018 10-K ↗
Working Capital (USD)	$617.01M	$533.33M	$647.31M	$181.54M	$248.91M	$335.87M	$382.02M	$431.28M	$188.63M	$139.83M	$169.31M	$91.21M	$215.57M	$230.58M	—	$120.44M	$64.22M	$76.71M	$71.69M	$79.42M	$99.59M	$52.16M	$67.78M	$27.34M	—	—	$65.86M	—	—	—	—
Total Equity (USD)	$629.98M	$545.93M	$658.86M	$192.26M	$259.44M	$344.33M	$388.75M	$437.92M	$195.07M	$44.21M	$77.69M	$99.38M	$119.60M	$133.48M	$126.65M	$133.25M	$51.32M	$64.41M	$83.28M	$102.30M	$119.43M	$64.41M	$79.45M	$36.86M	$53.60M	$68.41M	$78.86M	$36.18M	$43.56M	$57.59M	$-3.59M

📋 What is driving earnings? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q4 FY2018 Jan 31, 2019 10-K ↗	Q4 FY2017 Jan 31, 2018 10-K ↗
Sales/Revenue/Turnover (USD)	—	—	—	—	—	—	—	$0.00	—	—	$0.00	$0.00	$0.00	$0.00	$0.00	$220.00K	$235.00K	$250.00K	$251.00K	$1.31M	$57.00K	$192.00K	$185.00K	$181.00K	$170.00K	$324.00K	$-52.00K	$148.00K	—	—	—
Depreciation Expense (USD)	$46.00K	$44.00K	$42.00K	$42.00K	—	$25.00K	$22.00K	—	—	$27.00K	—	—	—	$90.00K	$88.00K	—	—	$69.00K	$79.00K	—	—	$80.00K	$35.00K	—	$103.00K	$72.00K	$53.00K	—	—	—	—
Net Income, GAAP (USD)	$-189.42M	$-189.42M	$-219.17M	$-62.91M	$-62.91M	$-62.91M	$-61.20M	$-56.25M	$-60.38M	$-43.47M	—	$-21.27M	$-14.72M	$-542.38M	$-19.23M	$-21.39M	$-16.77M	$-21.40M	$-27.10M	$-19.60M	$-24.42M	$-17.49M	$-13.54M	$-17.70M	$-15.28M	$-6.13M	$-9.08M	$-6.38M	—	—	—
Operating Cash Flow (USD)	$-141.12M	$-122.29M	$-101.94M	$-93.08M	—	$-61.17M	$-48.67M	—	—	$-30.13M	—	—	—	$-13.13M	$5.19M	—	—	$-19.00M	$-9.18M	—	—	$-20.67M	$-7.97M	—	$-18.53M	$-4.96M	$-6.90M	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 9 years · 31 quarters

Summit Therapeutics Inc.

Analytical Summary

31-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare SMMT with peers